Sunday, November 1, 2009

VeriChip to Collaborate with Diabetes Research Institute



Oct 27, 2009 (Close-Up Media via COMTEX) -- CHIP | Quote | Chart | News | PowerRating -- VeriChip Corp. has announced that it has entered into a strategic partnership with the Diabetes Research Institute (DRI) to combine efforts on the further development of the glucose-sensing radio frequency identification (RFID) microchip in conjunction with VeriChip's development partner, Receptors.

VeriChip and DRI said that they also intend to create a prospective, randomized, comparative clinical study that will seek to address the lack of appropriate, concise, and up-to-date patient health information available to both practitioners caring for diabetic patients and the patients themselves through the utilization of VeriChip's interoperable personal health record, Health Link, and an electronic medical record system.

Robert Pearlman, President and CEO of the DRI Foundation, said, "We are pleased to partner with VeriChip on this important initiative to develop a glucose-sensing RFID microchip, which could potentially improve patient care and compliance among individuals with diabetes. Furthermore, we believe access to a personal health record is vital for all patients, but particularly those with chronic illnesses. Our relationship with VeriChip will enable us to provide that access to our patients and study the utility of Health Link and the role it plays within a larger electronic medical record system."

VeriChip previously announced in November 2008 that Receptors completed Phase I of the development of the glucose-sensing RFID microchip, which demonstrated the proof-of-concept foundation of the glucose-sensing system. The companies expect Phase II will demonstrate a glucose concentration response in the presence of blood and interstitial fluid matrix components. The companies published a white paper entitled, "Development of an Implantable Glucose Sensor," which outlines the product's development and is available at verichipcorp.com.

VeriChip Corp., headquartered in Delray Beach, Florida, has developed the VeriMed Health Link System for identifying people who arrive in an emergency room and are unable to communicate.

((Comments on this story may be sent to health@closeupmedia.com))
For full details on Verichip Corporation (CHIP) click here. Verichip Corporation (CHIP) has Short Term PowerRatings of 7. Details on Verichip Corporation (CHIP) Short Term PowerRatings is available at This Link.

No comments:

Post a Comment